Gene · 9900
Papers2,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of Selective Small-Molecule Ligands of SV2C by AI-Enhanced Virtual Screening and Experimental Validation. | bioRxiv | 2026 | 42818081 | PubTator, text mining | PubMed |
| Interrogation of noncoding schizophrenia risk variants using CRISPR-based functional genomics. | bioRxiv | 2026 | 42779610 | PubTator, text mining | PubMed |
| Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma. | Nat Med | 2026 | 42754728 | PubTator, text mining | PubMed |
| Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review. | J Neurol | 2026 | 42704496 | PubTator, text mining | PubMed |
| Perampanel in real-world epilepsy setting: results from the PERSICILIA study. | Epilepsy Behav | 2026 | 42697052 | PubTator, text mining | PubMed |
| Exploratory imaging in SWEDD: Insights from dopaminergic PET, synaptic density PET, and volumetric MRI. | Parkinsonism Relat Disord | 2026 | 42691866 | PubTator, text mining | PubMed |
| In vivo imaging of synaptic density in psychotropic-free adults with autism spectrum disorder: a [¹¹C]UCB-J PET study. | Mol Psychiatry | 2026 | 42661058 | PubTator, text mining | PubMed |
| Transcriptional Profiling of Botulinum Neurotoxin Type A-Related Molecular Components in Primary Human Schwann Cells. | Toxins (Basel) | 2026 | 42646749 | PubTator, text mining | PubMed |
| Reconciling molecular persistence and functional recovery: A hybrid four-layer computational model of botulinum neurotoxin A. | Toxicon | 2026 | 42624296 | PubTator, text mining | PubMed |
| Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging. | Mol Diagn Ther | 2026 | 42579090 | PubTator, text mining | PubMed |
| Beyond FDG: a paradigm shift in precision localization of epileptogenic zones in refractory epilepsy using multimodal molecular imaging (PET/CT) and isotropic 3D MRI fusion. | J Neurol | 2026 | 42496724 | PubTator, text mining | PubMed |
| Biochemical modulators of synaptic plasticity: New horizons in Alzheimer's disease treatment. | J Alzheimers Dis | 2026 | 42489531 | PubTator, text mining | PubMed |
| Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration. | Eur J Clin Pharmacol | 2026 | 42479220 | PubTator, text mining | PubMed |
| Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. | Epilepsia | 2026 | 42470359 | PubTator, text mining | PubMed |
| Imaging biomarkers in neurodegenerative diseases: advances and challenges. | Front Aging Neurosci | 2026 | 42459525 | PubTator, text mining | PubMed |
| Psilocybin's effect on human brain synaptic plasticity. | Transl Psychiatry | 2026 | 42457666 | PubTator, text mining | PubMed |
| Fully Automated Azeotropic Drying-Free Synthesis of [18F]SynVesT-1 via Copper-Mediated Fluorination Using the Trasis All-in-One Module. | Molecules | 2026 | 42451763 | PubTator, text mining | PubMed |
| Efficacy of fenfluramine in a pediatric epilepsy patient with a pathogenic SV2A variant: A case report. | Epileptic Disord | 2026 | 42423542 | PubTator, text mining | PubMed |
| Brivaracetam as viable monotherapy option for focal and generalized epilepsy. | Epilepsy Behav | 2026 | 42400971 | PubTator, text mining | PubMed |
| Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses. | J Neuroinflammation | 2026 | 42399983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9900/papers